Financial Results For The Quarter Ended June 30, 2025
Awaiting price reaction for this filing.
Garodia Chemicals reported zero revenue for Q1 FY26 (quarter ended June 30, 2025), with a net loss of ₹5.81 lakhs versus a loss of ₹0.77 lakhs in the same quarter last year. Loss per share stood at ₹0.08. Total expenses rose to ₹5.81 lakhs from ₹0.77 lakhs, driven mainly by other expenses of ₹5.06 lakhs and employee costs of ₹0.75 lakhs. The company's auditor flagged four 'Emphasis of Matter' items, most critically that management has decided to cease the company's business operations and the financial statements are no longer prepared on a going concern basis. Other auditor concerns include unconfirmed creditor/debtor balances pending reconciliation, insufficient evidence on contingent liabilities, and the absence of an internal audit system. The Board meeting was held on August 14, 2025.
This is a deeply negative signal — management has formally decided to shut down the company's business, meaning the stock now trades on the basis of an asset wind-down rather than ongoing operations. Shareholders face a high risk of value erosion with no prospects of operational recovery, and the stock is likely to see significant downward pressure.